Aptevo Therapeutics (APVO) Inventory (2015 - 2019)
Aptevo Therapeutics (APVO) posted Inventory of $6.1 million for Q4 2019, down 17.95% sequentially from $7.5 million in Q3 2019, and up 243.92% YoY from $1.8 million in Q4 2018.
Aptevo Therapeutics (APVO) Inventory (2015 - 2019) Analysis & Trends
Aptevo Therapeutics has reported Inventory for 5 years, with the latest figure at $6.1 million in Q4 2019.
- Quarterly Inventory rose 243.92% year-over-year to $6.1 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $6.1 million (up 243.92% YoY) and the FY2019 annual result came in at $6.1 million, up 243.92% from the prior year.
- Inventory slipped to $6.1 million in Q4 2019 per APVO's latest filing, from $7.5 million in the prior quarter.
- Over five years, Inventory peaked at $20.3 million in Q4 2015 and troughed at $461000.0 in Q4 2016.
- A 5-year average of $6.6 million and a median of $5.2 million in 2019 frame the typical range for Inventory.
- The sharpest annual moves came in 2016 and 2019: Inventory sank 97.73% in 2016, then soared 243.92% in 2019.
- Over 5 years, Inventory stood at $20.3 million in 2015, then tumbled by 97.73% to $461000.0 in 2016, then surged by 122.99% to $1.0 million in 2017, then jumped by 73.64% to $1.8 million in 2018, then jumped by 243.92% to $6.1 million in 2019.
- According to Business Quant data, Inventory over the past three periods registered $6.1 million, $7.5 million, and $7.0 million for Q4 2019, Q3 2019, and Q2 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 97.11 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 128.86 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 142.38 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Aptevo Therapeutics | 3.18 Mn | -6.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 6.14 Mn |
| Sep 30, 2019 | 7.48 Mn |
| Jun 30, 2019 | 6.97 Mn |
| Mar 31, 2019 | 4.35 Mn |
| Dec 31, 2018 | 1.79 Mn |
| Sep 30, 2018 | 3.97 Mn |
| Jun 30, 2018 | 2.97 Mn |
| Mar 31, 2018 | 1.29 Mn |
| Dec 31, 2017 | 1.03 Mn |
| Sep 30, 2017 | 1.24 Mn |
| Jun 30, 2017 | 7.98 Mn |
| Mar 31, 2017 | 8.06 Mn |
| Dec 31, 2016 | 461,000.00 |
| Sep 30, 2016 | 11.57 Mn |
| Jun 30, 2016 | 20.13 Mn |
| Dec 31, 2015 | 20.32 Mn |